无症状颈动脉狭窄三种血运重建方式倾向匹配比较
基于TriNetX数据库2015至2025年接受CAS、TCAR或CEA的无症状颈动脉狭窄成人,进行倾向评分匹配分析。1年随访显示CAS卒中风险高于TCAR和CEA,但死亡率低于TCAR,MI低于TCAR,MAE高于CEA。观察性结果需谨慎解读。
要点
- CAS卒中风险高于TCAR和CEA,TCAR与CEA相近。
- CAS死亡率低于TCAR,MI低于TCAR,其余比较无差异。
- CAS的MAE高于CEA,CAS与TCAR、TCAR与CEA间无差异。
核心结论
- 在选定血运重建的无症状颈动脉狭窄患者中,CAS卒中风险高于TCAR和CEA,MI和死亡率低于TCAR,MAE高于CEA。
研究设计与样本
- 使用TriNetX数据库识别2015至2025年因无症状颈动脉狭窄接受CAS、TCAR或CEA的成人,无症状定义为术前6个月内无卒中或TIA。
- 进行倾向评分匹配:CAS vs TCAR 5,558对,TCAR vs CEA 9,666对,CAS vs CEA 13,707对,评估1年结局。
主要发现
- 1年卒中风险:CAS 5.16% vs TCAR 3.74%(RR 1.31;P=0.002);CAS 4.92% vs CEA 3.47%(RR 1.44;P<0.001);TCAR 3.91% vs CEA 3.79%(P=0.52)。
- 1年死亡率:CAS 3.78% vs TCAR 7.65%(RR 0.49;P<0.001),其余比较无差异。
- 1年MI:CAS 2.03% vs TCAR 2.95%(RR 0.63;P<0.001),其余比较无差异。
- 1年MAE:CAS 7.66% vs CEA 6.46%(RR 1.20;P<0.001),CAS与TCAR、TCAR与CEA间无差异。
临床怎么用
- 在为无症状颈动脉狭窄患者选择血运重建方式时,可参考本观察性数据权衡CAS的卒中风险与TCAR的死亡和MI风险。
- TCAR与CEA在卒中和MAE方面表现相近,CAS的MAE高于CEA。
局限性
- 观察性研究存在残余混杂,且缺乏解剖学数据,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To compare myocardial infarction (MI), stroke, mortality, and major adverse events (MAEs) after carotid artery stenting (CAS), transcarotid artery revascularization (TCAR), and carotid endarterectomy (CEA). METHODS: Using TriNetX, adults undergoing CAS, TCAR, or CEA for asymptomatic carotid stenosis from 2015 to 2025 were identified using International Classification of Diseases 10th Edition Procedure Coding System (ICD-10-PCS) codes. Asymptomatic status required no stroke or transient ischemic attack within 6 months before surgery. Propensity score matching was performed for CAS versus TCAR (5,558 pairs), TCAR versus CEA (9,666 pairs), and CAS versus CEA (13,707 pairs). Outcomes through 1 year were assessed using risk ratios (RRs) kand Kaplan-Meier analyses. RESULTS: At 1 year, CAS was associated with higher stroke risk than TCAR (5.16% vs 3.74%; RR 1.31; P = 0.002) and CEA (4.92% vs 3.47%; RR 1.44; P < 0.001), whereas TCAR and CEA were similar (3.91% vs 3.79%; P = 0.52). CAS had lower mortality than TCAR (3.78% vs 7.65%; RR 0.49; P < 0.001), but mortality was similar in the other comparisons. MI was lower after CAS than TCAR (2.03% vs 2.95%; RR 0.63; P < 0.001), with no differences otherwise. MAE was higher after CAS than CEA (7.66% vs 6.46%; RR 1.20; P < 0.001), but similar between CAS and TCAR and between TCAR and CEA. CONCLUSION: Among patients selected for revascularization, CAS was associated with higher stroke risk than TCAR and CEA, lower MI and mortality than TCAR, and higher MAE than CEA. These observational findings complement randomized evidence and require cautious interpretation given residual confounding and unavailable anatomic data.
引用
- Singh A, Sbaih OI, Prvulovic ST, et al. Comparative Outcomes of Carotid Artery Stenting, Transcarotid Artery Revascularization, and Carotid Endarterectomy in Asymptomatic Carotid Stenosis: A Propensity-Matched Analysis. Ann Vasc Surg. 2026. PMID: 42833588. doi:10.1016/j.avsg.2026.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。